|
I claim the ornamental design for a nosepiece unit, as shown and described.
|
The broken lines of even length shown in the drawings illustrate portion of the nosepiece unit that form no part of the claimed design. The broken lines of uneven length shown in the drawings define the unclaimed boundary of the claimed design.
Patent | Priority | Assignee | Title |
10076615, | Apr 05 2007 | OPTINOSE, INC | Nasal delivery |
10112021, | Jun 08 2006 | OPTINOSE, INC | Intranasal administration |
10252010, | Oct 03 2007 | OPTINOSE, INC | Nasal delivery devices |
10286164, | May 20 2003 | OPTINOSE, INC | Delivery device and method |
10398859, | Sep 15 2004 | OPTINOSE, INC | Nasal delivery devices |
10525218, | Nov 28 2006 | OPTINOSE, INC | Nasal delivery devices |
10639437, | Nov 28 2006 | OPTINOSE, INC | Delivery devices |
10639438, | Nov 28 2006 | OPTINOSE, INC | Delivery devices |
10722667, | Apr 05 2007 | OPTINOSE, INC | Nasal administration |
10737045, | Aug 28 2003 | OPTINOSE, INC | Delivery devices |
10765829, | Jul 25 2006 | OPTINOSE, INC | Delivery of gases to the nasal airway |
10864334, | Mar 23 2006 | OPTINOSE, INC | Nasal delivery |
11033696, | Feb 24 2012 | OPTINOSE, INC | Nasal delivery devices |
11083858, | Oct 03 2007 | OPTINOSE, INC | Nasal delivery devices |
11291626, | Sep 14 2011 | OPTINOSE, INC | Nasal delivery of oxytocin |
11554229, | Mar 26 2013 | OPTINOSE, INC | Nasal administration |
11571531, | Feb 23 2005 | OPTINOSE, INC | Powder delivery devices |
11602603, | Oct 03 2007 | OPTINOSE, INC | Nasal delivery devices |
11690969, | Jul 25 2006 | OPTINOSE, INC | Delivery of gases to the nasal airway |
11707586, | Nov 19 2014 | OPTINOSE, INC | Intranasal administration |
11730904, | Nov 19 2014 | OPTINOSE, INC | Intranasal administration |
12083270, | Feb 14 2006 | OPTINOSE, INC | Delivery device and method |
9522243, | Jul 02 2002 | OPTINOSE, INC | Nasal devices |
9949923, | Mar 15 2011 | OPTINOSE, INC | Nasal delivery |
D809128, | May 23 2013 | OPTINOSE, INC | Nosepiece unit |
D896645, | Nov 08 2018 | LINDAL FRANCE SAS | Aerosol actuator |
D934073, | Jul 24 2019 | APTAR RADOLFZELL GMBH | Spray head |
D935318, | Jul 24 2019 | APTAR RADOLFZELL GMBH | Spray head |
ER2053, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
May 23 2013 | OptiNose AS | (assignment on the face of the patent) | / | |||
Aug 05 2013 | DJUPESLAND, PER GISLE | OptiNose AS | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042703 | /0957 | |
Aug 05 2015 | DJUPESLAND, PER GISLE | OptiNose AS | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 042704 | /0226 | |
Dec 29 2017 | OptiNose AS | ATHYRIUM OPPORTUNITIES III ACQUISITION LP | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 044976 | /0505 | |
Sep 12 2019 | OptiNose AS | BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 050371 | /0913 | |
Sep 12 2019 | ATHYRIUM OPPORTUNITIES III ACQUISITION LP | OptiNose AS | RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 | 050371 | /0894 | |
Mar 13 2023 | OptiNose AS | OPTINOSE, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 062974 | /0206 | |
Dec 10 2024 | OPTINOSE, INC | OPTINOSE, INC | CHANGE OF ADDRESS | 069825 | /0458 |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |